Eurofins Scient (OTCMKTS:ERFSF – Get Free Report) shares saw unusually-strong trading volume on Monday . Approximately 6,668 shares traded hands during mid-day trading, an increase of 21% from the previous session’s volume of 5,505 shares.The stock last traded at $68.3520 and had previously closed at $68.7380.
Analyst Ratings Changes
Separately, Citigroup reaffirmed a “neutral” rating on shares of Eurofins Scient in a report on Monday, February 2nd. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold”.
Get Our Latest Stock Report on ERFSF
Eurofins Scient Trading Up 1.5%
About Eurofins Scient
Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.
Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.
Read More
- Five stocks we like better than Eurofins Scient
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
- Brady Corp Wires Up a Massive AI-Powered Breakout
- Why Home Depot’s Sell-Off Could Become a Huge Opportunity
Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.
